| Legend: no star : Special Mention | : Important | ![]() : Very Important | ![]() ![]() : Key Development |
||
![]() |
A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T, J Viral Hepat. 2009 Apr;16(4):259-64 |
|
![]() |
Survival in Asian Americans after treatments for hepatocellular carcinoma: aseven-year experience at UCLA. Tong MJ, Chavalitdhamrong D, Lu DS, Raman SS, Gomes A, Duffy JP, Hong JC,Busuttil RW., J Clin Gastroenterol. 2010 Mar;44(3):e63-70. |
|
![]() |
Hepatitis B virus infection among American patients with chronic hepatitis Cvirus infection: prevalence, racial/ethnic differences, and viral interactions. Bini EJ, Perumalswami PV., Hepatology. 2010 Mar;51(3):759-66. |
|
![]() |
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. Mendy ME, Welzel T, Lesi OA, Hainaut P, Hall AJ, Kuniholm MH, McConkey S, GoedertJJ, Kaye S, Rowland-Jones S, Whittle H, Kirk GD., J Viral Hepat. 2010 Feb 1;17(2):115-22. Epub 2009 Oct 27. |
|
![]() |
Naturally occurring amino-acid substitutions to nucleos(t)ide analogues intreatment naive Turkish patients with chronic hepatitis B. Sayan M, Akhan SC, Meric M., J Viral Hepat. 2010 Jan;17(1):23-7. Epub 2009 Jun 28. |
|
![]() |
Interaction of adipokines and hepatitis B virus on histological liver injury inthe Chinese. Wong VW, Wong GL, Yu J, Choi PC, Chan AW, Chan HY, Chu ES, Cheng AS, Chim AM,Chan FK, Sung JJ, Chan HL., Am J Gastroenterol. 2010 Jan;105(1):132-8. Epub 2009 Oct 6. |
|
![]() ![]() |
HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL, Gastroenterology. 2008 Oct;135(4):1192-9 |
|
![]() |
Screening and early treatment of migrants for chronic hepatitis B virus infectionis cost-effective. Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH., Gastroenterology. 2010 Feb;138(2):522-30. Epub 2009 Oct 29. |
|
| The prevalence and clinical correlates of elevated ALT levels in an urbanChinatown community. Cotler SJ, Dhamija MK, Luc BJ, Siqueira F, Bartram AH, Layden TJ, Wong SS., J Viral Hepat. 2010 Feb 1;17(2):148-52. Epub 2009 Aug 6. |
||
| Prevalence of hepatitis B surface antigen among refugees entering the UnitedStates between 2006 and 2008. Rein DB, Lesesne SB, O'Fallon A, Weinbaum CM., Hepatology. 2010 Feb;51(2):431-4. |
||
| Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Sun HY, Ko WC, Tsai JJ, Lee HC, Liu CE, Wong WW, Su SC, Ho MW, Cheng SH, Yang CH, Lin YH, Miao WJ, Sheng WH, Hung CC, Am J Gastroenterol. 2009 Apr;104(4):877-84 |
||
| Epidemiology of hepatocellular carcinoma in Japan. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K, J Gastroenterol. 2009;44 Suppl 19:102-7 |
||
| How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore. Ong SC, Lim SG, Li SC, J Viral Hepat. 2009 Jan;16(1):53-63 |
||
| Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK, J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5 |
||
| Study of the Association Between Polymorphisms of the COL1A1 Gene and HBV-Related Liver Cirrhosis in Chinese Patients. Zhao YP, Wang H, Fang M, Ji Q, Yang ZX, Gao CF Dig Dis Sci. 2008 Jun 7; |
||
| Supplementary evidence: | ||
| Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW, Gut. 2008 Dec;57(12):1713-20 |
||
| HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, Chen QY, Fang KX, Yang JY, Wang XY, Harrison TJ, Am J Gastroenterol. 2008 Sep;103(9):2254-62 |
||